drugset / Trial / NCT02531672

Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography

NCT02531672 ↗

Expanded access No longer available Memorial Sloan Kettering Cancer Center

Summary

The purpose of this study is to use a new imaging drug called 11C-choline that is used with a PET/CT scan to see prostate cancer when it cannot be seen well on other scans, such as bone scans, CT or MRI.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject 11C-Choline Diagnostic / imaging agent — —

Indications